Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration.

J Ophthalmol · 2014 · PMC4121253 · PMID 25110587

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

There was no significant difference in aqueous VEGF levels ( P = 0.38) between baseline and 8 weeks after injection, although levels decreased in most cases and a decreasing trend was discernible ( Figure 1(a) ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.